[Anti IL-2 receptor antibody--basiliximab]

Nihon Rinsho. 2005 May:63 Suppl 5:713-7.

[Article in Japanese]

Authors

Yuki Nakagawa¹, Kazuhide Saitou, Kota Takahashi

Affiliation

¹ Division of Urology, Department of Regenerative and Transplant Medicine, Graduate School of Medical and Dental Sciences, Niigata University.

PMID: 15954434

No abstract available

Publication types

Review

MeSH terms

Antibodies, Monoclonal* / administration & dosage
Antibodies, Monoclonal* / chemistry
Antibodies, Monoclonal* / pharmacokinetics
Antibodies, Monoclonal* / pharmacology
Basiliximab
Drug Therapy, Combination
Graft Rejection / prevention & control
Humans
Immunosuppressive Agents* / administration & dosage
Immunosuppressive Agents* / chemistry
Immunosuppressive Agents* / pharmacokinetics
Immunosuppressive Agents* / pharmacology
Interleukin-2
Kidney Transplantation
Methylprednisolone / administration & dosage
Randomized Controlled Trials as Topic
Receptors, Interleukin-2 / immunology
Recombinant Fusion Proteins* / administration & dosage
Recombinant Fusion Proteins* / chemistry
Recombinant Fusion Proteins* / pharmacokinetics
Recombinant Fusion Proteins* / pharmacology

Substances

Antibodies, Monoclonal
Immunosuppressive Agents
Interleukin-2
Receptors, Interleukin-2
Recombinant Fusion Proteins
Basiliximab
Methylprednisolone